< Back to situations

[ORGANIZATION]

Mantecorp

Featured in 4 tracked stories · first seen

Situations

[QUIET] [HEALTH] [BR]

Semaglutide regulatory approvals and pricing in Brazil

8 clusters · 112 sources · last updated

Latest: Brazil expands access to obesity and diabetes treatments

Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject

Also covered in